News
Featured News
Flexibility, creativity, and dedication to make better therapeutics are at the heart of what we do. Read more on recent updates and highlights around our contract drug manufacturing activities.
BIOVECTRA is Honoured With 2025 CDMO Leadership Award, BIOLOGICS — Industry Recognizes BIOVECTRA’s Excellence in Microbial Fermentation, Recombinant Protein Production, and Aseptic Fill-Finish Capabilities.
March 6, 2025
BIOVECTRA Welcomes Normand Blais to Senior Director, Development & Innovation, Biologics Role
Charlottetown, P.E.I. (January 18, 2023) – BIOVECTRA is pleased to announce that Normand Blais was appointed as Senior Director, Development & Innovation, Biologics. Reporting […]
BIOVECTRA Named One of Canada’s Top Employers Again in 2023
Charlottetown, P.E.I. (November 22, 2022) – BIOVECTRA was selected as one of Canada’s Top 100 Employers for a second consecutive year and is considered […]
BIOVECTRA Expands Manufacturing Capacity with Single-Use Microbial Fermentation Technology
Charlottetown, CANADA, October 31, 2022 – BIOVECTRA is ready to accept projects at its manufacturing facility in Windsor, Nova Scotia, Canada, for its new, […]
BIOVECTRA Named to True North List of Leading Canadian Companies
CHARLOTTETOWN, PEI – BIOVECTRA was recently named to Communitech’s True North list as one of Canada’s high performing tech companies that has a promising […]
BIOVECTRA Starts Construction on its Charlottetown mRNA Biomanufacturing Centre
Charlottetown, P.E.I. (April 14, 2022) – BIOVECTRA broke ground today, with help from provincial and federal officials, on a cutting-edge facility that will manufacture […]
BIOVECTRA mRNA Vaccine and Bio-manufacturing Facility Announced
Charlottetown, P.E.I. (November 18, 2021) – BIOVECTRA today announced plans for the development of a state-of-the-art facility specializing in the production and manufacturing of […]
